Progress in Lung Cancer Management: Experts' Perspectives on Medical Advances
Editat de Deruo Liuen Limba Engleză Hardback – 12 dec 2024
Preț: 738.84 lei
Preț vechi: 777.72 lei
-5% Nou
Puncte Express: 1108
Preț estimativ în valută:
141.39€ • 148.70$ • 118.14£
141.39€ • 148.70$ • 118.14£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789819900886
ISBN-10: 9819900883
Pagini: 240
Ilustrații: Approx. 240 p. 50 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:2024
Editura: Springer Nature Singapore
Colecția Springer
Seria Experts' Perspectives on Medical Advances
Locul publicării:Singapore, Singapore
ISBN-10: 9819900883
Pagini: 240
Ilustrații: Approx. 240 p. 50 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:2024
Editura: Springer Nature Singapore
Colecția Springer
Seria Experts' Perspectives on Medical Advances
Locul publicării:Singapore, Singapore
Cuprins
Diagnosis of pulmonary nodules and selection of surgical timing.- Advances in Artificial Intelligence diagnosis and Clinical Localization of pulmonary nodules.- Selection of therapeutic modalities for cIA stage non-small cell lung cancer.- Selection of induction and adjuvant therapy for lung cancer.- Surgical treatment of locally advanced lung cancer: augmentation angioplasty and bronchial sleeve resection.- Stereotactic radiotherapy vs. surgery for early non-small cell lung cancer .- Surgical treatment of oligometastases in non-small cell lung cancer.- Treatment strategies for limited stage small cell lung cancer.
Notă biografică
Editor Deruo Liu is a chief physician at the Thoracic Surgery department, China-Japan Friendship Hospital, Beijing, China.
Textul de pe ultima copertă
This book introduces the latest progress of diagnosis and treatment of lung cancer. The first part focuses on the latest advances in screening, diagnosis and staging of lung cancer. The second part focuses on the operation and adjuvant therapy of lung cancer. It highlights recent application of the minimally invasive surgery, molecular targeted therapy and immunotherapy.
The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com). A subsequent human revision was done primarily in terms of content.
Caracteristici
Highlights the benefits of Low-Dose Spiral CT Scanning Technology and HRCT Introduces the recent progress in molecular targeted therapy and immunotherapy Covers the management tools for different stages of lung cancer